Balance Sheet Amphenol Corporation

Equities

APH

US0320951017

Electronic Equipment & Parts

Market Closed - Nyse Other stock markets 21:00:03 15/04/2026 BST			5-day change	1st Jan Change
146.98 ^USD	-1.17%		+8.62%	+8.76%

04-14	UBS Adjusts Price Target on Amphenol to $170 From $174, Maintains Buy Rating	MT
04-08	Citigroup Adjusts Price Target on Amphenol to $170 From $180, Maintains Buy Rating	MT

8e7c0.pPSZdplJXf75Fh3AZpQQucVrYwMgXj6tudjMrFPNe7Q.0ZX4QOEZMrXIeC6mHO5TwfM5ImV6KAiYz4K42Wq1C4fmh6sy1A48lJ9YWA

Published financial data: AMPHENOL CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	10.88B	12.62B	12.55B	15.22B	23.09B
Total Revenues	10.88B	12.62B	12.55B	15.22B	23.09B
Cost of Goods Sold, Total	7.47B	8.59B	8.47B	10.06B	14.5B
Gross Profit	3.4B	4.03B	4.08B	5.16B	8.6B
Selling General & Admin Expenses, Total	916M	1.1B	1.15B	1.4B	1.9B
R&D Expenses	318M	324M	342M	453M	647M
Other Operating Expenses, Total	1.23B	1.42B	1.49B	1.86B	2.55B
Operating Income	2.17B	2.61B	2.59B	3.3B	6.05B
Interest Expense, Total	-116M	-128M	-140M	-217M	-368M
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-116M	-128M	-140M	-217M	-368M
Other Non Operating Income (Expenses)	6.6M	11.6M	29.7M	71.9M	101M
EBT, Excl. Unusual Items	2.06B	2.49B	2.48B	3.16B	5.78B
Merger & Related Restructuring Charges	-70.4M	-21.5M	-34.6M	-146M	-181M
Other Unusual Items	-	-	5.4M	-	-
EBT, Incl. Unusual Items	1.99B	2.47B	2.45B	3.01B	5.6B
Income Tax Expense	409M	551M	509M	570M	1.3B
Earnings From Continuing Operations	1.58B	1.92B	1.95B	2.44B	4.31B
Earnings Of Discontinued Operations	21.4M	-	-	-	-
Net Income to Company	1.6B	1.92B	1.95B	2.44B	4.31B
Minority Interest	-10.7M	-14.5M	-17.5M	-17.6M	-35M
Net Income - (IS)	1.59B	1.9B	1.93B	2.42B	4.27B
Net Income to Common Incl Extra Items	1.59B	1.9B	1.93B	2.42B	4.27B
Net Income to Common Excl. Extra Items	1.57B	1.9B	1.93B	2.42B	4.27B
Per Share Items
Net EPS - Basic	1.33	1.6	1.62	2.01	3.51
Basic EPS - Continuing Operations	1.31	1.6	1.62	2.01	3.51
Basic Weighted Average Shares Outstanding	1.2B	1.19B	1.19B	1.2B	1.22B
Net EPS - Diluted	1.27	1.53	1.56	1.92	3.34
Diluted EPS - Continuing Operations	1.26	1.53	1.56	1.92	3.34
Diluted Weighted Average Shares Outstanding	1.25B	1.24B	1.24B	1.26B	1.28B
Normalized Basic EPS	1.07	1.29	1.29	1.62	2.94
Normalized Diluted EPS	1.02	1.24	1.24	1.55	2.8
Dividend Per Share	0.32	0.4	0.42	0.55	0.74
Payout Ratio	21.79	25.1	25.96	24.55	18.79
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	2.56B	3B	3B	3.88B	6.97B
EBITA	2.25B	2.69B	2.68B	3.46B	6.24B
EBIT	2.17B	2.61B	2.59B	3.3B	6.05B
EBITDAR	2.68B	3.12B	3.13B	4.03B	7.17B
Effective Tax Rate - (Ratio)	20.57	22.31	20.75	18.93	23.13
Current Domestic Taxes	86.8M	97.7M	55.1M	19M	212M
Current Foreign Taxes	352M	458M	513M	634M	1.15B
Total Current Taxes	439M	555M	568M	653M	1.36B
Deferred Domestic Taxes	-35.4M	-31.5M	-10M	-56.2M	-165M
Deferred Foreign Taxes	5.8M	26.8M	-48.8M	-26.6M	99.5M
Total Deferred Taxes	-29.6M	-4.7M	-58.8M	-82.8M	-65.6M
Normalized Net Income	1.28B	1.54B	1.54B	1.96B	3.58B
Interest on Long-Term Debt	116M	128M	140M	217M	368M
Non-Cash Pension Expense	7M	1.6M	400K	-100K	1.4M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	318M	324M	342M	453M	647M
Net Rental Expense, Total	118M	121M	127M	156M	202M
Imputed Operating Lease Interest Expense	23.88M	25.14M	29.82M	45.49M	50.79M
Imputed Operating Lease Depreciation	94.32M	96.26M	97.28M	111M	151M
Stock-Based Comp., SG&A Exp. (Total)	83M	89.5M	99M	110M	135M
Total Stock-Based Compensation	83M	89.5M	99M	110M	135M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.2B	1.37B	1.48B	3.32B	11.13B
Short Term Investments	44.3M	61.1M	185M	18.4M	304M
Total Cash And Short Term Investments	1.24B	1.43B	1.66B	3.34B	11.43B
Accounts Receivable, Total	2.45B	2.63B	2.62B	3.29B	4.72B
Total Receivables	2.45B	2.63B	2.62B	3.29B	4.72B
Inventory	1.89B	2.09B	2.17B	2.55B	3.42B
Prepaid Expenses	368M	320M	390M	517M	691M
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	5.96B	6.48B	6.84B	9.69B	20.27B
Gross Property Plant And Equipment	3.38B	3.51B	3.88B	4.56B	5.96B
Accumulated Depreciation	-1.96B	-2.02B	-2.26B	-2.46B	-3.1B
Net Property Plant And Equipment	1.42B	1.49B	1.62B	2.1B	2.86B
Long-term Investments	-	-	400K	300K	200K
Goodwill	6.38B	6.45B	7.09B	8.24B	10.58B
Other Intangibles, Total	757M	734M	835M	1.23B	2.24B
Deferred Tax Assets Long-Term	91M	86.9M	98.5M	129M	182M
Other Long-Term Assets, Total	75.3M	86.2M	48.8M	67.7M	106M
Total Assets	14.68B	15.33B	16.53B	21.44B	36.24B
Liabilities
Accounts Payable, Total	1.31B	1.31B	1.35B	1.82B	2.66B
Accrued Expenses, Total	852M	985M	1.06B	1.36B	2.27B
Current Portion of Long-Term Debt	4M	2.7M	354M	402M	937M
Current Portion of Leases	70.6M	85.2M	91.6M	108M	141M
Current Income Taxes Payable	88.8M	170M	166M	199M	483M
Other Current Liabilities	120M	125M	132M	200M	307M
Total Current Liabilities	2.45B	2.68B	3.15B	4.08B	6.8B
Long-Term Debt	4.8B	4.58B	3.98B	6.48B	14.56B
Long-Term Leases	180M	208M	212M	286M	425M
Pension & Other Post Retirement Benefits	193M	128M	143M	130M	138M
Deferred Tax Liability Non Current	424M	410M	367M	377M	433M
Other Non Current Liabilities	258M	235M	242M	224M	364M
Total Liabilities	8.3B	8.23B	8.1B	11.58B	22.73B
Common Stock, Total	600K	600K	600K	1.2M	1.2M
Additional Paid In Capital	2.41B	2.65B	3.1B	3.6B	4.23B
Retained Earnings	4.28B	4.98B	5.92B	7.1B	9.85B
Treasury Stock	-100M	-79.8M	-143M	-200M	-196M
Comprehensive Income and Other	-286M	-535M	-534M	-716M	-480M
Total Common Equity	6.3B	7.02B	8.35B	9.79B	13.41B
Minority Interest	77.1M	78.5M	80M	64.1M	96.6M
Total Equity	6.38B	7.09B	8.43B	9.86B	13.51B
Total Liabilities And Equity	14.68B	15.33B	16.53B	21.44B	36.24B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.2B	1.19B	1.2B	1.21B	1.23B
ECS Total Common Shares Outstanding	1.2B	1.19B	1.2B	1.21B	1.23B
Book Value / Share	5.26	5.9	6.97	8.1	10.94
Tangible Book Value	-832M	-165M	419M	331M	596M
Tangible Book Value Per Share	-0.69	-0.14	0.35	0.27	0.49
Total Debt	5.05B	4.87B	4.64B	7.28B	16.07B
Net Debt	3.81B	3.44B	2.98B	3.94B	4.63B
Debt Equivalent of Unfunded Proj. Benefit Obligation	117M	93.2M	80.2M	50.9M	36.2M
Debt Equivalent Oper. Leases	946M	971M	1.02B	1.25B	1.61B
Minority Interest, Total (Incl. Fin. Div)	77.1M	78.5M	80M	64.1M	96.6M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	818M	930M	965M	1.1B	1.41B
Inventories - Work In Process, Total	512M	556M	562M	704M	960M
Inventories - Finished Goods, Total	564M	608M	640M	740M	1.05B
Land - (BS)	34.9M	30.2M	33.9M	47.7M	72.5M
Buildings, Total	421M	429M	484M	543M	702M
Machinery, Total	2.68B	2.76B	3.06B	3.59B	4.63B
Full Time Employees	90K	91K	95K	125K	170K
Accumulated Allowance for Doubtful Accounts (Supple)	43.5M	63.9M	68.4M	66.5M	99.3M
Order Backlog	3.81B	4.1B	4B	6.1B	8.9B

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1.59B	1.9B	1.93B	2.42B	4.27B
Depreciation & Amortization - CF	309M	312M	320M	418M	730M
Amortization of Goodwill and Intangible Assets - (CF)	86.4M	81M	86M	155M	192M
Depreciation & Amortization, Total	396M	393M	406M	572M	922M
Stock-Based Compensation (CF)	83M	89.5M	99M	110M	135M
Tax Benefit from Stock Options	-	-	-	-	-
Net Cash From Discontinued Operations	16.2M	-	-	-	-
Other Operating Activities, Total	-40.3M	9.8M	-46.7M	-65.2M	-30.6M
Change In Accounts Receivable	-398M	-273M	146M	-587M	-964M
Change In Inventories	-263M	-278M	71.4M	-200M	-487M
Change In Accounts Payable	132M	62.5M	-34.6M	423M	554M
Change In Income Taxes	-6.9M	77.6M	7.7M	3.1M	277M
Change in Other Net Operating Assets	31.4M	192M	-48.9M	135M	698M
Cash from Operations	1.54B	2.17B	2.53B	2.81B	5.37B
Capital Expenditure	-360M	-384M	-373M	-665M	-997M
Sale of Property, Plant, and Equipment	3.7M	5.6M	4M	7.8M	14.8M
Cash Acquisitions	-2.23B	-288M	-970M	-2.16B	-3.82B
Investment in Marketable and Equity Securities, Total	-8.6M	-81.2M	-59.4M	164M	-282M
Other Investing Activities, Total	703M	16.5M	4.9M	1.9M	-
Cash from Investing	-1.89B	-731M	-1.39B	-2.65B	-5.08B
Short Term Debt Issued, Total	796M	44.9M	-	-	-
Long-Term Debt Issued, Total	752M	5.8M	355M	2.99B	8.92B
Total Debt Issued	1.55B	50.7M	355M	2.99B	8.92B
Short Term Debt Repaid, Total	-	-204M	-633M	-	-
Long-Term Debt Repaid, Total	-913M	-10.3M	-15.7M	-364M	-402M
Total Debt Repaid	-913M	-214M	-648M	-364M	-402M
Issuance of Common Stock	288M	185M	394M	447M	553M
Repurchase of Common Stock	-662M	-730M	-585M	-689M	-665M
Common Dividends Paid	-347M	-477M	-501M	-595M	-802M
Common & Preferred Stock Dividends Paid	-347M	-477M	-501M	-595M	-802M
Other Financing Activities, Total	-61.1M	-10.3M	-27.8M	-60M	-182M
Cash from Financing	-145M	-1.2B	-1.01B	1.73B	7.42B
Foreign Exchange Rate Adjustments	-12.3M	-70.8M	-20.7M	-54M	97.8M
Net Change in Cash	-505M	176M	102M	1.84B	7.81B
Supplemental Items
Cash Interest Paid	112M	124M	129M	180M	288M
Cash Income Tax Paid (Refund)	446M	478M	560M	650M	1.08B
Levered Free Cash Flow	804M	1.53B	1.66B	1.64B	3.28B
Unlevered Free Cash Flow	876M	1.61B	1.74B	1.77B	3.51B
Change In Net Working Capital	598M	112M	11.1M	309M	332M
Net Debt Issued / Repaid	636M	-164M	-293M	2.63B	8.52B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	10.04	10.86	10.18	10.87	13.11
Return on Total Capital	12.92	13.92	12.95	13.67	16.18
Return On Equity %	26.71	28.45	25.07	26.71	36.85
Return on Common Equity	26.86	28.57	25.1	26.73	36.8
Margin Analysis
Gross Profit Margin %	31.28	31.91	32.53	33.88	37.22
SG&A Margin	8.42	8.71	9.14	9.21	8.23
EBITDA Margin %	23.58	23.76	23.9	25.46	30.18
EBITA Margin %	20.73	21.28	21.34	22.71	27.02
EBIT Margin %	19.94	20.64	20.66	21.7	26.19
Income From Continuing Operations Margin %	14.53	15.18	15.5	16.04	18.64
Net Income Margin %	14.63	15.07	15.36	15.92	18.49
Net Avail. For Common Margin %	14.43	15.07	15.36	15.92	18.49
Normalized Net Income Margin	11.74	12.21	12.23	12.85	15.5
Levered Free Cash Flow Margin	7.39	12.16	13.19	10.75	14.2
Unlevered Free Cash Flow Margin	8.05	12.79	13.88	11.64	15.2
Asset Turnover
Asset Turnover	0.81	0.84	0.79	0.8	0.8
Fixed Assets Turnover	8.06	8.66	8.07	8.2	9.31
Receivables Turnover (Average Receivables)	4.94	4.96	4.78	5.15	5.77
Inventory Turnover (Average Inventory)	4.45	4.31	3.98	4.27	4.86
Short Term Liquidity
Current Ratio	2.43	2.42	2.17	2.37	2.98
Quick Ratio	1.51	1.52	1.36	1.62	2.37
Operating Cash Flow to Current Liabilities	0.63	0.81	0.8	0.69	0.79
Days Sales Outstanding (Average Receivables)	73.94	73.53	76.31	71	63.26
Days Outstanding Inventory (Average Inventory)	81.95	84.67	91.8	85.69	75.15
Average Days Payable Outstanding	56.15	54.39	56.82	55.55	53.18
Cash Conversion Cycle (Average Days)	99.73	103.81	111.29	101.14	85.23
Long Term Solvency
Total Debt/Equity	79.18	68.67	55.08	73.86	118.93
Total Debt / Total Capital	44.19	40.71	35.52	42.48	54.32
LT Debt/Equity	78.01	67.43	49.79	68.69	110.95
Long-Term Debt / Total Capital	43.54	39.98	32.11	39.51	50.68
Total Liabilities / Total Assets	56.54	53.71	49.01	54.03	62.72
EBIT / Interest Expense	18.77	20.29	18.59	15.22	16.44
EBITDA / Interest Expense	23.22	24.3	22.42	18.58	19.5
(EBITDA - Capex) / Interest Expense	20.1	21.31	19.75	15.51	16.79
Total Debt / EBITDA	1.88	1.56	1.48	1.81	2.24
Net Debt / EBITDA	1.42	1.1	0.95	0.98	0.65
Total Debt / (EBITDA - Capex)	2.18	1.78	1.68	2.16	2.6
Net Debt / (EBITDA - Capex)	1.64	1.26	1.08	1.17	0.75
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	26.48	16.06	-0.54	21.25	51.71
Gross Profit, 1 Yr. Growth %	27.69	18.41	1.39	26.29	66.65
EBITDA, 1 Yr. Growth %	31.41	16.95	0.05	29.16	79.89
EBITA, 1 Yr. Growth %	33.21	19.15	-0.26	29.01	80.5
EBIT, 1 Yr. Growth %	31.98	20.16	-0.46	27.33	83.14
Earnings From Cont. Operations, 1 Yr. Growth %	30.23	21.31	1.5	25.5	76.33
Net Income, 1 Yr. Growth %	32.19	19.58	1.35	25.73	76.17
Normalized Net Income, 1 Yr. Growth %	34.17	20.72	-0.39	27.42	82.97
Diluted EPS Before Extra, 1 Yr. Growth %	28.06	21.91	1.63	23.87	73.96
Accounts Receivable, 1 Yr. Growth %	25.78	7.19	-0.49	25.57	43.47
Inventory, 1 Yr. Growth %	29.54	10.53	3.51	17.47	34.54
Net Property, Plant and Equip., 1 Yr. Growth %	11.04	5.18	8.19	29.7	36.66
Total Assets, 1 Yr. Growth %	19.07	4.41	7.83	29.73	69.01
Tangible Book Value, 1 Yr. Growth %	1.76K	-80.21	-354.74	-21.13	80.31
Common Equity, 1 Yr. Growth %	17.03	11.32	18.97	17.32	36.98
Cash From Operations, 1 Yr. Growth %	-3.26	41.2	16.28	11.31	90.95
Capital Expenditures, 1 Yr. Growth %	30.2	6.49	-2.87	78.49	49.77
Levered Free Cash Flow, 1 Yr. Growth %	-14.23	90.92	7.88	-1.18	100.51
Unlevered Free Cash Flow, 1 Yr. Growth %	-13.21	84.35	7.92	1.66	98.13
Dividend Per Share, 1 Yr. Growth %	22.12	27.56	4.94	29.41	35.45
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	14.99	21.16	7.44	9.82	35.63
Gross Profit, 2 Yr. CAGR %	14.03	22.96	9.57	13.16	45.07
EBITDA, 2 Yr. CAGR %	14.62	23.97	8.17	13.68	52.43
EBITA, 2 Yr. CAGR %	14.93	25.99	9.02	13.44	52.6
EBIT, 2 Yr. CAGR %	15	25.93	9.37	12.58	52.7
Earnings From Cont. Operations, 2 Yr. CAGR %	16.51	25.69	10.96	12.86	48.76
Net Income, 2 Yr. CAGR %	17.36	25.73	10.09	12.88	48.82
Normalized Net Income, 2 Yr. CAGR %	15.87	27.27	9.66	12.66	52.69
Diluted EPS Before Extra, 2 Yr. CAGR %	15.55	24.95	11.31	12.02	46.79
Accounts Receivable, 2 Yr. CAGR %	18.9	16.12	3.28	11.78	34.22
Inventory, 2 Yr. CAGR %	20.24	19.66	6.96	10.27	25.71
Net Property, Plant and Equip., 2 Yr. CAGR %	8.98	8.07	6.68	18.46	33.13
Total Assets, 2 Yr. CAGR %	16.5	11.5	6.11	18.28	48.08
Tangible Book Value, 2 Yr. CAGR %	3.34	91.89	-29	41.74	19.25
Common Equity, 2 Yr. CAGR %	17.94	14.14	15.08	18.14	26.77
Cash From Operations, 2 Yr. CAGR %	1.25	16.87	28.14	13.77	45.79
Capital Expenditures, 2 Yr. CAGR %	10.53	17.75	1.71	31.67	63.5
Levered Free Cash Flow, 2 Yr. CAGR %	-10.22	27.96	43.52	3.25	40.76
Unlevered Free Cash Flow, 2 Yr. CAGR %	-9.55	26.49	41.05	4.74	41.92
Dividend Per Share, 2 Yr. CAGR %	15.02	24.81	15.7	16.53	32.4
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.86	15.35	13.45	11.86	22.31
Gross Profit, 3 Yr. CAGR %	8.61	15.48	15.31	14.88	28.74
EBITDA, 3 Yr. CAGR %	8.86	15.39	15.42	14.76	32.47
EBITA, 3 Yr. CAGR %	9.13	16.32	16.55	15.31	32.43
EBIT, 3 Yr. CAGR %	8.71	16.7	16.44	15.05	32.41
Earnings From Cont. Operations, 3 Yr. CAGR %	9.1	18.09	17.05	15.61	30.96
Net Income, 3 Yr. CAGR %	9.7	18.1	17.01	15.07	30.94
Normalized Net Income, 3 Yr. CAGR %	8.98	17.47	17.29	15.28	32.42
Diluted EPS Before Extra, 3 Yr. CAGR %	9.25	17.63	16.64	15.23	29.72
Accounts Receivable, 3 Yr. CAGR %	11.06	14.86	10.29	10.23	21.48
Inventory, 3 Yr. CAGR %	15.36	16.91	14.01	10.36	17.83
Net Property, Plant and Equip., 3 Yr. CAGR %	17.48	7.7	8.11	13.86	24.24
Total Assets, 3 Yr. CAGR %	13.48	12.32	10.26	13.46	33.22
Tangible Book Value, 3 Yr. CAGR %	19.77	-40.43	110.9	-26.47	53.58
Common Equity, 3 Yr. CAGR %	16.2	15.69	15.73	15.82	24.11
Cash From Operations, 3 Yr. CAGR %	11.44	13.12	16.68	22.26	35.2
Capital Expenditures, 3 Yr. CAGR %	5.08	9.17	10.43	22.68	37.45
Levered Free Cash Flow, 3 Yr. CAGR %	1.56	15.45	20.89	26.73	28.82
Unlevered Free Cash Flow, 3 Yr. CAGR %	1.78	14.68	19.97	26.46	29.54
Dividend Per Share, 3 Yr. CAGR %	13.01	19.06	17.8	20.1	22.53
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	11.59	12.48	8.89	13.1	21.85
Gross Profit, 5 Yr. CAGR %	10.77	11.76	9	14.54	26.4
EBITDA, 5 Yr. CAGR %	12.18	12.78	8.58	14.7	29
EBITA, 5 Yr. CAGR %	11.97	12.89	9.09	15.16	29.82
EBIT, 5 Yr. CAGR %	12.07	12.96	8.97	15.03	29.78
Earnings From Cont. Operations, 5 Yr. CAGR %	13.67	23.74	9.84	15.97	28.83
Net Income, 5 Yr. CAGR %	14.09	23.94	9.86	15.98	28.83
Normalized Net Income, 5 Yr. CAGR %	11.94	12.97	9.25	15.52	30.34
Diluted EPS Before Extra, 5 Yr. CAGR %	13.98	24.33	10.07	15.35	27.79
Accounts Receivable, 5 Yr. CAGR %	12.71	10.48	7.88	13.62	19.3
Inventory, 5 Yr. CAGR %	15.32	13.59	11.92	14.21	18.56
Net Property, Plant and Equip., 5 Yr. CAGR %	14.83	12.83	13.04	11.88	17.5
Total Assets, 5 Yr. CAGR %	11.55	8.91	10.47	14.67	24.07
Tangible Book Value, 5 Yr. CAGR %	11.7	-19.75	-2.83	-15.74	67.89
Common Equity, 5 Yr. CAGR %	11.39	11.95	15.75	16.67	20.02
Cash From Operations, 5 Yr. CAGR %	7.4	13.7	17.84	13.38	27.55
Capital Expenditures, 5 Yr. CAGR %	13.56	11.11	3.72	17.67	29.2
Levered Free Cash Flow, 5 Yr. CAGR %	2.27	16.61	16.63	10.41	28.47
Unlevered Free Cash Flow, 5 Yr. CAGR %	2.77	15.98	15.97	10.6	28.31
Dividend Per Share, 5 Yr. CAGR %	16.97	18.27	14.08	18.04	23.43